Srujan (Sru) Jamindar serves as Executive Director of Venture Engagement within the clinical research business of Thermo Fisher Scientific. In that role he manages relationships with venture capital firms that PPD Biotech has partnered with. He is responsible for actualizing commercial and strategic success from VC partnerships, and provides strategic direction to current and future VC relationships.
Sru joined the business in 2021, prior to which he managed the portfolio of strategic alliances and investments at BCBSNC. Prior to that he held roles in commercial finance and alliance management at Syneos Health. Earlier in his career at IQVIA Sru held roles of increasing impact, starting as an analyst in the Quintiles-NovaQuest venture arm and the corporate development group, and culminating with a director role on the strategic pricing and partnering team.
Prior to entering the CRO world, Sru worked in genome sequencing and bioinformatics for biotech startups Athenix and Paradigm Genetics. Sru holds a Finance MBA and a BS in Biochemistry from North Carolina State University. During his undergraduate studies, he conducted research at the NIH on the induction of apoptosis in various cancer cell lines.